ClinicalTrials.Veeva
Menu

Find clinical trials for Triple Negative Breast Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Ovarian Cancer
Cancer
Colorectal Cancer
Endometrial Cancer

Triple Negative Breast Cancer trials near Nashville, TN, USA:

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

The purpose of this study is to determine if a combination of two drugs sacituzumab govitecan and atezolizumab works as a treatment for residual cancer...

Enrolling
Breast Cancer
Triple Negative Breast Cancer
Drug: Atezolizumab
Drug: Sacituzumab govitecan

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 6 other locations

(SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC).The pri...

Enrolling
Triple Negative Breast Cancer
Drug: Sacituzumab Govitecan-hziy (SG)

Phase 1, Phase 2

Gilead Sciences
Gilead Sciences

Nashville, Tennessee, United States and 15 other locations

selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...

Active, not recruiting
Breast Cancer
Renal Cell Carcinoma
Drug: nab-paclitaxel
Drug: Bevacizumab

Phase 2

Infinity Pharmaceuticals
Infinity Pharmaceuticals

Nashville, Tennessee, United States and 23 other locations

This study tests an investigational cancer vaccine called ITI-5000 in people who have completed standard treatment for early-stage triple...

Enrolling
Triple Negative Breast Cancer (TNBC)
Biological: ITI-5000 MTD (Maximum Tolerated Dose)
Drug: Olaparib

Phase 1

Immunomic Therapeutics

Nashville, Tennessee, United States and 1 other location

avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...

Active, not recruiting
Stage IIIA Breast Cancer
Recurrent Breast Carcinoma
Biological: Utomilumab
Biological: Anti-OX40 Antibody PF-04518600

Phase 2

Laura Huppert, MD, BA

Nashville, Tennessee, United States and 11 other locations

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patie...

Active, not recruiting
Triple Negative Breast Cancer (TNBC)
Urothelial Cancer
Drug: ADRX-0706

Phase 1

Adcentrx Therapeutics

Nashville, Tennessee, United States and 20 other locations

This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...

Active, not recruiting
Hormone Receptor Positive Breast Cancer
Non-small Cell Lung Cancer
Drug: Steroid Containing Mouthwash
Other: Non-Steroid Containing Mouthwash

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Nashville, Tennessee, United States and 17 other locations

levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple...

Active, not recruiting
Locally Advanced Breast Cancer
Metastatic Triple Negative Breast Cancers
Drug: BNT327 Equivalent Q3W Dose
Drug: BNT327 Dose Level 1 (DL2)

Phase 2

BioNTech
BioNTech

Nashville, Tennessee, United States of America and 33 other locations

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...

Active, not recruiting
Triple Negative Breast Cancer
PD-L1 Negative
Drug: Sacituzumab Govitecan-hziy
Drug: Paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

Nashville, Tennessee, United States and 374 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...

Active, not recruiting
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Gilead Sciences
Gilead Sciences

Nashville, Tennessee, United States and 506 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems